SCHEMBL1983595

SCHEMBL1983595

CC(C)Cc1cccc(CCCO)c1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.44
GABRB2 P47870 1/20 0.44
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
SIGMAR1 Q99720 2/20 0.36
KMT2A Q03164 1/20 0.36
GCGR P47871 2/20 0.35
TSHR P16473 1/20 0.33
MC4R P32245 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
BCL2 P10415 1/20 0.33
MCL1 Q07820 1/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4368693 0.79 PDCD1 (0.43) PDCD1CD274GCGRTSHRMCL1
SCHEMBL1983593 0.77 GABRA1 (0.46) GABRA1GABRB2PDCD1CD274SIGMAR1
SCHEMBL28329969 0.73 GABRA1 (0.59) GABRA1GABRB2KMT2APOLBALDH1A1
Hydrogen Peroxide SCHEMBL5685702 0.71 GABRA1 (0.65) GABRA1GABRB2SIGMAR1POLB
SCHEMBL1535892 0.70 DPP4 (0.54) PDCD1CD274KMT2APOLBALDH1A1
SCHEMBL10525253 0.70 GABRA1 (0.54) GABRA1GABRB2KMT2ATSHR
SCHEMBL4630258 0.70 KMT2A (0.60) GABRA1GABRB2PDCD1CD274KMT2A
SCHEMBL27546468 0.70 BCL2L1 (0.46) PDCD1CD274KMT2AMCL1ALDH1A1
SCHEMBL35210163 0.70 GABRA1 (0.39) GABRA1GABRB2BCL2MCL1ALDH1A1
SCHEMBL1156949 0.70 GABRA1 (0.42) GABRA1GABRB2KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2504323-A1 NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY Allergan, Inc. (US) 2012-10-03 EP disclosed
WO-2011066184-A1 NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY ALLERGAN, INC. (US) 2011-06-03 WO disclosed